Correction: Statins for primary prevention of cardiovascular events in people with HIV: target trial and modelling study

Correction: Statins for primary prevention of cardiovascular events in people with HIV: target trial and modelling study

Saved in:

Bibliographic Details
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2025-07-01
Series:	BMJ Medicine
Online Access:	https://bmjmedicine.bmj.com/content/4/1/e001132corr1.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Statins for primary prevention of cardiovascular events in people with HIV: target trial and modelling study
by: Sarah R Haile, et al.
Published: (2025-07-01)

Statins for extension of disability-free survival and primary prevention of cardiovascular events among older people: protocol for a randomised controlled trial in primary care (STAREE trial)
by: Rory Wolfe, et al.
Published: (2023-04-01)

PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

Choosing lipid lowering statin in risk strategy of cardiovascular event prevention
by: A. Ya. Yvleva, et al.
Published: (2007-02-01)

UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES
by: N. F. Puchin'yan, et al.
Published: (2015-12-01)

Effectiveness of patient-oriented intervention in primary prevention of cardiovascular diseases with statins: Open-label randomized study
by: Elena Bochkareva, et al.
Published: (2025-06-01)

ROSUVASTATIN - THE MOST POTENT STATIN IN CARDIOVASCULAR DISEASE PREVENTION
by: A. E. Semenova, et al.
Published: (2018-06-01)

Prediction of cardiovascular events in statin-treated stable coronary patients of the treating to new targets randomized controlled trial by lipid and non-lipid biomarkers.
by: Benoit J Arsenault, et al.
Published: (2014-01-01)

Physician perspectives on statin continuation and discontinuation in older adults in primary cardiovascular prevention: a qualitative methods study
by: Claudio Schneider, et al.
Published: (2024-10-01)

STATIN ROLE IN CARDIOVASCULAR DISEASE PREVENTION AND TREATMENT (AN EXAMPLE OF SIMVASTATIN)
by: M. A. Gurevich
Published: (2010-04-01)

Frailty, Pitavastatin, and Major Adverse Cardiovascular Events Among People With HIV
by: Kristine M. Erlandson, MD, MS, et al.
Published: (2025-09-01)

Correction: Statin-induced risk of diabetes does not reduce cardiovascular benefits in primary prevention: a 6-year propensity-score matched study in a large population
by: Maria Lembo, et al.
Published: (2025-07-01)

Do Statin Users Adhere to Dietary Recommendations for Cardiovascular Disease Prevention?
by: Milica Zrnic Ciric, et al.
Published: (2024-02-01)

STATINS IN THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES: REPETITION OF THE PAST AND OPTIMISM FOR THE FUTURE
by: L. N. Malay
Published: (2015-09-01)

Absolute risk-based versus individualized benefit approaches for determining statin eligibility in primary prevention of cardiovascular diseases in Chinese populations: A modeling study.
by: Qiuping Liu, et al.
Published: (2025-07-01)

Absolute risk-based versus individualized benefit approaches for determining statin eligibility in primary prevention of cardiovascular diseases in Chinese populations: A modeling study
by: Qiuping Liu, et al.
Published: (2025-07-01)

When are statins cost-effective in cardiovascular prevention? A systematic review of sponsorship bias and conclusions in economic evaluations of statins.
by: Ferrán Catalá-López, et al.
Published: (2013-01-01)

WCN25-1139 ANTIPLATLET AND STATIN THERAPY FOR THE PRIMARY PREVENTION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN HEMODIALYSIS PATIENTS: A CASE-CONTROL STUDY
by: Passawee Chevasath, et al.
Published: (2025-02-01)

Burden and Predictors of Statin Use for Primary and Secondary Prevention of Cardiovascular Disease in Bangladesh: Evidence from a Nationally Representative Survey
by: Shehab Uddin Al Abid, et al.
Published: (2025-03-01)

Statin utilization and its predictors for the primary prevention of cardiovascular disease among type 2 diabetic patients in a resource-limited setting
by: Feyisa Assefa Dhaba, et al.
Published: (2025-07-01)

Statin effects on the lipidome: Predicting statin usage and implications for cardiovascular risk prediction
by: Changyu Yi, et al.
Published: (2025-05-01)

Statin Utilization for Primary Prevention of Cardiovascular Disease in Patients Developing First ST‐Segment Elevation Myocardial Infarction: A Malaysian Retrospective Cohort Study
by: Abdullah Faiz Zaihan, et al.
Published: (2025-03-01)

Statin use and low-density lipoprotein cholesterol target achievement for primary prevention of atherosclerotic cardiovascular disease in patients with type 2 diabetes mellitus: a multicenter cross-sectional study in Sri Lanka.
by: P D W D De Zoysa, et al.
Published: (2025-01-01)

STATINS IN PREVENTION OF ISCHEMIC STROKE
by: A. V. Susekov, et al.
Published: (2015-09-01)

Correction for ‘Long-term comparative effectiveness of antihypertensive monotherapies in primary prevention of cardiovascular events: a population-based retrospective inception cohort study in the Netherlands’
Published: (2024-02-01)

Statin-induced risk of diabetes does not reduce cardiovascular benefits in primary prevention: a 6-year propensity-score matched study in a large population
by: Maria Lembo, et al.
Published: (2025-05-01)

EARLY DISTURBANCES OF CARBOHYDRATE METABOLISM — A TARGET FOR PRIMARY CARDIOVASCULAR PREVENTION
by: M. N. Kovrigina, et al.
Published: (2013-04-01)

Methods and validity indicators for measuring adherence to statins in secondary cardiovascular prevention: a systematic review
by: Adriana López-Pineda, et al.
Published: (2025-05-01)

Bempedoic Acid for Prevention of Cardiovascular Events in People With Obesity: A CLEAR Outcomes Subset Analysis
by: Harold E. Bays, et al.
Published: (2025-02-01)

Correction of Hypercholesterolemia in Primary and Secondary Prevention of Cardiovascular Diseases: Features and Controversial Issues
by: N. M. Akhmedzhanov, et al.
Published: (2019-01-01)

Statin Effects on Aggression: Results from the UCSD Statin Study, a Randomized Control Trial.
by: Beatrice A Golomb, et al.
Published: (2015-01-01)

Statins in Secondary Prevention of Atrial Fibrillation
by: V. I. Podzolkov, et al.
Published: (2016-11-01)

THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT PREVENTS OVERCOMING STATINOPHOBIA?
by: S. N. Bel'diev
Published: (2016-06-01)

Association of Cardiologist Clinic Visits With Cardiovascular Primary Prevention Outcomes Among People With HIV From Underrepresented Racial and Ethnic Groups in the Southern United States
by: Matthew S. Durstenfeld, et al.
Published: (2025-03-01)

Chinese Guideline on the Primary Prevention of Cardiovascular Diseases: Time to Start Better Cardiovascular Primary Prevention
by: Guang Ning, et al.
Published: (2021-06-01)

Insufficient use of statins in the primary and secondary prevention of myocardial infarction: an urgent problem in modern cardiology
by: N. G. Lozhkina, et al.
Published: (2025-04-01)

Statins: Cardiovascular Risk Reduction in Percutaneous Coronary Intervention—Basic and Clinical Evidence of Hyperacute Use of Statins
by: Enrique C. Morales-Villegas, et al.
Published: (2011-01-01)

Personalized statin therapy: Targeting metabolic processes to modulate the therapeutic and adverse effects of statins
by: Zhuangqi Shi, et al.
Published: (2025-01-01)

RHEUMATOID ARTHRITIS AND CARDIOVASCULAR RISK: PERSPECTIVES OF TREATMENT WITH STATINS
by: D. A. Anichkov, et al.
Published: (2015-12-01)

Impact of Statin Nonacceptance on Cardiovascular Outcomes in Patients With Diabetes
by: Nisarg Shah, et al.
Published: (2025-06-01)